Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-3230-2017Class II

Platinium CRT DF1 1711, Model Number TDF033U, UDI/GTIN 08031527015538, Implantable cardioverter...

Corcym Inc. / initiated 2017-07-24 / Terminated / root cause: software

Sorin Group Italia SRL - CRF began a recall of Platinium CRT DF1 1711, Model Number TDF033U, UDI/GTIN 08031527015538, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia... on . FDA classified it as Class II and gives the reason as "There is a possibility of overconsumption of certain PLATINIUM Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) following an ElectroStatic Discharge (ESD) during...". As of , the recall status on record is Terminated, and MDM tags the root cause as software.

Recall record

Recall number
Z-3230-2017
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Corcym Inc.
Product
Platinium CRT DF1 1711, Model Number TDF033U, UDI/GTIN 08031527015538, Implantable cardioverter defibrillator, Biventricular or ventricular antitachycardia pacing, Dual or single chamber arrhythmia detection Product Usage: PLATINIUM VR is indicated for use in patients who are at high risk of sudden cardiac death due to ventricular tachyarrhythmias and who have experienced one of the following situations: - Survival of at least one episode of cardiac arrest (manifested by the loss of consciousness) due to ventricular tachyarrhythmia, - Recurrent, poorly tolerated sustained ventricular tachycardia (VT).
Product code
NIK Defibrillator, Automatic Implantable Cardioverter, With Cardiac Resynchronization (Crt-D)
Reason for recall
There is a possibility of overconsumption of certain PLATINIUM Implantable Cardiac Defibrillators (ICDs) and Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) following an ElectroStatic Discharge (ESD) during the implant surgery or a Magnetic Resonance Imaging (MRI) scan, and what actions to take.
Root cause tag
software
FDA root cause
Software design
Action
LivaNova issued a communication to physicians treating patients implanted with the products in scope in the form of a customer letter beginning July 24, 2017. The letter instructs users to do the following: 1. In order to mitigate the potential risks associated with both triggering events (ESD at implant or MRI scan), LivaNova recommends physicians follow the patients at the periodicity already stated in the implant manual, especially: " Before the patient is discharged and at each subsequent follow-up, it is advisable to check the battery status and the occurrence of system warnings; " It is recommended that a routine follow-up examination be done one month after discharge, and then every three months until the device nears the replacement date.
Quantity in commerce
154 units
Distribution
US Nationwide Distribution
Product codes and lots
All Serial Numbers

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-3230-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-3228-2017Class IITerminatedVoluntary: Firm initiated
Z-3229-2017Class IITerminatedVoluntary: Firm initiated
Z-3230-2017Class IITerminatedVoluntary: Firm initiated
Z-3231-2017Class IITerminatedVoluntary: Firm initiated
Z-3232-2017Class IITerminatedVoluntary: Firm initiated
Z-3233-2017Class IITerminatedVoluntary: Firm initiated